Overview

Randomized Controlled Clinical Stardy on Wumeiwan Jiawei Fang Use in Patients With Blepharospasm

Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Jing Fang Wu Mei Wan Jiawei Fang in the treatment of idiopathic blepharospasm using a clinical randomized controlled trial method.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
China Academy of Chinese Medical Sciences
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A